The in vitro effects of all-trans-retinoic acid and hematopoietic growth factors on the clonal growth and self-renewal of blast stem cells in acute promyelocytic leukemia

Leukemia Research

Volumn 21, Issue 4, 1997, Pages 285-294

  Miyauchi, Jun ^a   Inatomi, Yuka ^a,b   Ohyashiki, Kazuma ^b   Asada, Minoru ^c   Mizutani, Shuki ^c   Toyama, Keisuke ^b  

^a NATIONAL CHILDREN S HOSPITAL   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute promyelocytic leukemia; G CSF; Leukemic stem cell; Retinoic acid

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; INTERLEUKIN 3; RETINOIC ACID;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; CELL PROLIFERATION; CLINICAL ARTICLE; COLONY FORMATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL; HUMAN; LEUKEMIA CELL; LYMPHOCYTE CLONE; MALE; PRIORITY JOURNAL; PROMYELOCYTE;

EID: 0030910716     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(96)00069-0     Document Type: Article

References (38)

1. McCulloch E. A., Howatson A. F., Buick R. N., Minden M. D. & Izaquirre C. A. Acute myeloblastic leukemia considered as a clonal hemopathy. Blood Cells, 1979, 5, 261.
2. McCulloch E. A., Minden M. D., Miyauchi J., Kelleher C. A. & Wang C. Stem cell renewal and differentiation in acute myeloblastic leukaemia. Journal of Cell Science, 1988, 10, Suppl., 267.
3. Buick R. N., Minden M. D. & McCulloch E. A. Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia. Blood, 1979, 54, 95.
4. Curtis J. E., Messner H. A., Hasselback R., Elhakim T. M. & McCulloch E. A. Contributions of host-and disease-related attributes to the outcome of patients with acute myelogenous leukemia. Journal of Clinical Oncology, 1984, 2, 253.
5. Miyauchi J., Kelleher C., Yang Y.-C., Wong G., Clark S. C., Minden M. D., Minkin S. & McCulloch E. A. The effects of three recombinant growth factors, IL-3, GM-CSF, and G-CSF, on the blast cells of acute myeloblastic leukemia maintained in short-term suspension culture. Blood, 1987, 70, 657.
6. Miyauchi J., Kelleher C., Wong G., Yang Y.-C., Clark S. C., Minkin S., Minden M. D. & McCulloch E. A. The effects of combinations of the recombinant growth factors GM-CSF, G-CSF, IL-3, and CSF-1 on leukemic blast cells in suspension culture. Leukemia, 1988, 2, 382.
7. Miyauchi J., Kelleher C. A., Wang C., Minkin S. & McCulloch E. A. Growth factors influence the sensitivity of leukemic stem cells to cytosine arabinoside in culture. Blood, 1989, 73, 1272.
8. Inatomi Y., Toyama K., Clark S. C., Shimizu K. & Miyauchi J. Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia. Cancer Research, 1994, 54, 455.
9. + acute myeloblastic leukemia colony-forming cells in response to recombinant hematopoietic growth factors. Leukemia, 1990, 4, 561.
10. Löwenberg B., Salem M. & Delwel R. Effects of recombinant multi-CSF, GM-CSF, G-CSF and M-CSF on the proliferation and maturation of human AML in vitro. Blood Cells, 1988, 14, 539.
11. Lista P., Porcu P., Avanzi G. C. & Pegoraro L. Interleukin-3 enhances the cytotoxic activity of 1-beta-D arabinofuranosylcytosine (ara-C) on acute myeloblastic leukaemia (AML) cells. British Journal of Haematology, 1988, 70, 121.
12. Canniatra S. A., Groshek P. & Griffin J. D. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and myeloid blast crisis phase of chronic myeloid leukemia. Leukemia, 1989, 3, 328.
13. Ohno R., Tomonaga M., Kobayashi T., Kanamaru A., Shirakawa S., Masaoka T., Omine M., Oh H., Nomura T., Sakai Y., Hirano M., Yokomaku S., Nakayama S., Yoshida Y., Miura A., Morishima Y., Dohy H., Niho Y., Hamajima N. & Takaku F. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia. New England Journal of Medicine, 1990, 323, 871.
14. Estey E., Thall P. H., Kantarjian H., O'brien S., Koller C. A., Beran M., Gutterman J., Deisseroth A. & Keating M. Treatment of newly diagnosed acute myelogenous leukemia with granulocyte-macrophage colony-stimulating actor (GM-CSF) before and during continuous-infusion high-dose ara-C+daunorubicin: comparison to patients treated without GM-CSF. Blood, 1992, 79, 2246.
15. Larson R. A., Kondo K., Vardiman J. W., Butler A. E., Golomb H. M. & Rowle J. D. Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia. American Journal of Medicine, 1984, 76, 827.
16. Borrow J., Goddard A. D., Sheer D. & Solomon E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science, 1990, 24, 1577.
17. de Thé H., Chomienne C., Lanotte M., Degos L. & Dejean A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locus. Nature, 1990, 347, 558.
18. Alcalay M., Zangrilli D., Pandolfi P. P., Longo L., Mencarelli A., Giacomucci A., Rocchi M., Biondi A., Rambaldi A., Lo Coco F., Diverio D., Donti E., Grignani F. & Pelicci P. G. Translocation breakpoint of acute promyelocytic leukemia lies within the retinoic acid receptor α locus. Proceedings of the National Academy of Sciences, U.S.A., 1991, 88, 1977.
19. Grignani F., Fagioli M., Alcalay M., Longo L., Pandolfi P. P., Donti E., Biondi A., Lo Coco F., Grignani F. & Pelicci P. P. Acute promyelocytic leukemia: from genetics to treatment. Blood, 1994, 83, 10.
20. Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P. & Degos L. All-trans-retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood, 1990, 76, 1704.
21. Chomienne C., Ballerini P., Balitrand N., Daniel M. T., Fenaux P., Castaigne S. & Degos L. All-trans-retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood, 1990, 76, 1710.
22. Warrell R. P.Jr, Frankel S. R., Miller W. H.Jr, Scheinberg D. A., Itri L. M., Hittelman W. N., Vyas R., Andreeff M., Tafuri A., Jakubowski A., Gabrilove J., Gordon M. S. & Dmitrovsky E. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). New England Journal of Medicine, 1991, 324, 1385.
23. Warrell R. P. Jr Retinoid resistance in acute promyelocytic leukemia: new mechanisms, strategies, and implications. Blood, 1993, 82, 1949.
24. Laczika K., Mitterbauer G., Korninger L., Knöbl P., Schwarzinger I., Kapiotis S., Haas O. A., Kyrle P. A., Pont J., Oehler L., Purtscher B., Thalhammer F., Lechner K. & Jaeger U. Rapid achievement of PML-RARα polymerase chain reaction (PCR)-negativity by combined all-trans-retinoic acid treatment and chemotherapy in promyelocytic leukemia: a pilot study. Leukemia, 1994, 8, 1.
25. Fenaux P., Deley M. C. L., Castaigne S., Archimbaud E., Chomienne C., Link H., Guerci A., Duarte M., Daniel M. T., Bowen D., Huebner G., Bauters F., Fegueux N., Fey M., Sanz M., Löwenberg B., Maloisel F., Auzanneau G., Sadoun A., Gardin C., Bastion Y., Ganser A., Jacky E., Dombret H., Chastang C. & Degos L. The European APL 91 Group: effect of all-trans-retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood, 1993, 82, 3241.
26. Nakamaki T., Sakashita A., Sano M., Hino K., Suzuki K., Tomoyasu S., Tsuruoka N., Honma Y. & Hozumi M. Granulocyte-colony stimulating factor and retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells in vitro. Japanese Journal of Cancer Research, 1989, 80, 1077.
27. + myelomonocytic leukemia cells by retinoic acid and granulocyte colony-stimulating factor. Leukemia Research, 1992, 16, 571.
28. Gianni M., Terao M., Zanotta S., Barbui T., Rambaldi A. & Garattini E. Retinoic acid and granulocyte colony-stimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood, 1994, 83, 1909.
29. Pébusque M.-J., Lafage M., Lopez M. & Mannoni P. Preferential response of acute myeloid leukemias with translocation involving chromosome 17 to human recombinant granulocyte colony-stimulating factor. Blood, 1988, 72, 257.
30. Claxton D. F., Reading C. L., Nagarajan L., Tsujimoto Y., Andersson B. S., Estey E., Cork A., Huh Y. O., Trujillo J. & Deisseroth A. B. Correlation of CD2 expression with PML gene breakpoints in patients with acute promyelocytic leukemia. Blood, 1992, 80, 582.
31. Chomczynski P. & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Annals of Biochemistry, 1987, 162, 156.
32. Pandolfi P. P., Alcalay M., Fagioli M., Zangrilli D., Mencarelli A., Diverio D., Biondi A., Lo Coco F., Rambaldi A., Grignani F., Rochette-Egly C., Gaube M.-P., Chambon P. & Pelicci P. G. Genomic variability and alternative splicing generate multiple PML/RARα transcripts that encode aberrant PML proteins and PML/RARα isoforms in acute promyelocytic leukaemia. EMBO Journal, 1992, 11, 1397.
33. Geng J. P., Tong J. H., Dong S., Wang Z. Y., Chen S. J., Chen Z., Zelent A., Berger R. & Larsen C.-J. Localization of the chromosome 15 breakpoints and expression of multiple PML-RARα transcripts in acute promyelocytic leukemia: a study of 28 Chinese patients. Leukemia, 1993, 7, 20.
34. McCulloch E. A., Kelleher C. A., Miyauchi J., Wang C., Cheng G. Y. N., Minden M. D. & Curtis J. E. Heterogeneity in acute myeloblastic leukemia. Leukemia, 1988, 2, Suppl., 38S.
35. Lawrence H. J., Conner K., Kelly M. A., Haussler M. R., Wallace P. & Bagny G. C. Jr cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. Blood, 1987, 69, 302.
36. + BM cells. Annals of Hematology, 1993, 66, 61.
37. Gratas C., Menot M. L., Dresch C. & Chomienne C. Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia, 1993, 7, 1156.
38. Dubois C., Schlageter M. H., de Gentile A., Guidez F., Balitrand N., Toubert M. E., Krawice I., Fenaux P., Castaigne S., Najean Y., Degos L. & Chomienne C. Hematopoietic growth factor expression and ATRA sensitivity in acute promyelocytic blast cells. Blood, 1994, 83, 3264.